Skip to main content

Molecular Devices Shares Slide 5.13 Percent After Bank Downgrades Stock

NEW YORK, July 6 (GenomeWeb News) - Shares in Molecular Devices were down 5.13 percent, or $1.13, at $20.67 in mid-afternoon trading after an investment bank downgraded the company's stock.


Thomas Weisel downgraded the shares to 'Peer Perform' from 'Outperform.'

The Scan

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.